Literature DB >> 22822385

LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene.

E Martínez-Quintana1, F Rodríguez-González.   

Abstract

LEOPARD syndrome (LS) is an acronym consisting of lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary valve stenosis, abnormal genitalia, retardation of growth and deafness. However, hypertrophic cardiomyopathy, the most frequent cause of sudden cardiac death in young people, is the most common cardiovascular manifestation in LS patients and the major determinant of mortality and morbidity. In approximately 85% of the patients with a definite diagnosis of LS, a missense mutation is found in the protein-tyrosine phosphatase non-receptor type 11 (PTPN11) gene located on chromosome 12q24.1. We report the case of an asymptomatic 17-year-old male with a missense mutation (c.836A>G) in exon 7 (Tyr279Cys) of the PTPN11 gene and a non-obstructive asymmetric anteroseptal hypertrophic cardiomyopathy.

Entities:  

Year:  2012        PMID: 22822385      PMCID: PMC3362168          DOI: 10.1159/000335995

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  11 in total

1.  Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome.

Authors:  A Sarkozy; E Conti; M Cristina Digilio; B Marino; E Morini; G Pacileo; M Wilson; R Calabrò; A Pizzuti; B Dallapiccola
Journal:  J Med Genet       Date:  2004-05       Impact factor: 6.318

Review 2.  Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.

Authors:  Imke Christiaans; Klaartje van Engelen; Irene M van Langen; Erwin Birnie; Gouke J Bonsel; Perry M Elliott; Arthur A M Wilde
Journal:  Europace       Date:  2010-01-29       Impact factor: 5.214

3.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Authors:  Marco Tartaglia; Kamini Kalidas; Adam Shaw; Xiaoling Song; Dan L Musat; Ineke van der Burgt; Han G Brunner; Débora R Bertola; Andrew Crosby; Andra Ion; Raju S Kucherlapati; Steve Jeffery; Michael A Patton; Bruce D Gelb
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

4.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Eur Heart J       Date:  2006-09       Impact factor: 29.983

5.  PTPN11 mutations in LEOPARD syndrome.

Authors:  E Legius; C Schrander-Stumpel; E Schollen; C Pulles-Heintzberger; M Gewillig; J-P Fryns
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

6.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

Review 7.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

8.  Genotype-phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome.

Authors:  Giuseppe Limongelli; Anna Sarkozy; Giuseppe Pacileo; Paolo Calabrò; Maria Cristina Digilio; Valeria Maddaloni; Giulia Gagliardi; Giovanni Di Salvo; Maria Iacomino; Bruno Marino; Bruno Dallapiccola; Raffaele Calabrò
Journal:  Am J Med Genet A       Date:  2008-03-01       Impact factor: 2.802

9.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Authors:  Bhaswati Pandit; Anna Sarkozy; Len A Pennacchio; Claudio Carta; Kimihiko Oishi; Simone Martinelli; Edgar A Pogna; Wendy Schackwitz; Anna Ustaszewska; Andrew Landstrom; J Martijn Bos; Steve R Ommen; Giorgia Esposito; Francesca Lepri; Christian Faul; Peter Mundel; Juan P López Siguero; Romano Tenconi; Angelo Selicorni; Cesare Rossi; Laura Mazzanti; Isabella Torrente; Bruno Marino; Maria C Digilio; Giuseppe Zampino; Michael J Ackerman; Bruno Dallapiccola; Marco Tartaglia; Bruce D Gelb
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

Review 10.  Leopard syndrome.

Authors:  Anna Sarkozy; Maria Cristina Digilio; Bruno Dallapiccola
Journal:  Orphanet J Rare Dis       Date:  2008-05-27       Impact factor: 4.123

View more
  7 in total

1.  Leopard syndrome: a report of five cases from one family in two generations.

Authors:  Fatima Begić; Husref Tahirović; Mediha Kardašević; Ingrid Kalev; Kai Muru
Journal:  Eur J Pediatr       Date:  2014-01-09       Impact factor: 3.183

2.  LEOPARD Syndrome: Clinical Features and Gene Mutations.

Authors:  E Martínez-Quintana; F Rodríguez-González
Journal:  Mol Syndromol       Date:  2012-08-29

3.  Recombinant human growth hormone in the treatment of C.836A/G-caused short stature in a girl: a case report and literature review.

Authors:  Xiaoxia Qian; Huangping Zhang; Caixia Xiang
Journal:  Transl Pediatr       Date:  2022-05

4.  Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Authors:  Jae-Sung Yi; Sravan Perla; Yan Huang; Kana Mizuno; Frank J Giordano; Alexander A Vinks; Anton M Bennett
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-10       Impact factor: 3.947

5.  LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies.

Authors:  Claudia Santoro; Giuseppe Pacileo; Giuseppe Limongelli; Saverio Scianguetta; Teresa Giugliano; Giulio Piluso; Fulvio Della Ragione; Mario Cirillo; Giuseppe Mirone; Silverio Perrotta
Journal:  BMC Med Genet       Date:  2014-04-26       Impact factor: 2.103

Review 6.  The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss.

Authors:  Lourdes Rodríguez-de la Rosa; Luis Lassaletta; Miryam Calvino; Silvia Murillo-Cuesta; Isabel Varela-Nieto
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

7.  Multimodality Imaging of LEOPARD Syndrome: Myocardial Hypertrophy With Diffuse Coronary Artery Dilation.

Authors:  Dan Yang; Yining Wang; Minjie Lu
Journal:  JACC Case Rep       Date:  2022-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.